Kumlesh K. Dev

Dublin, L, Ireland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Pharmacokinetic Study of Fingolimod Nasal Films Administered via Nose-to-Brain Route in C57BL/6 J Mice as Potential Treatment for Multiple Sclerosis.

Pharmacokinetic Study of Fingolimod Nasal Films Administered via Nose-to-Brain Route in C57BL/6 J Mice as Potential Treatment for Multiple Sclerosis.

Journal: Pharmaceutical research

Published: April 21, 2024

The Effect of Donepezil Hydrochloride in the Twitcher Mouse Model of Krabbe Disease.

The Effect of Donepezil Hydrochloride in the Twitcher Mouse Model of Krabbe Disease.

Journal: Molecular neurobiology

Published: January 09, 2024

The Effects of the S1P Receptor Agonist Fingolimod (FTY720) on Central and Peripheral Myelin in Twitcher Mice.

The Effects of the S1P Receptor Agonist Fingolimod (FTY720) on Central and Peripheral Myelin in Twitcher Mice.

Journal: Biomedicines

Published: October 17, 2023

Olaparib Attenuates Demyelination and Neuroinflammation in an Organotypic Slice Culture Model of Metachromatic Leukodystrophy.

Olaparib Attenuates Demyelination and Neuroinflammation in an Organotypic Slice Culture Model of Metachromatic Leukodystrophy.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: July 13, 2023

The Effects of Antipsychotics in Experimental Models of Krabbe Disease.

The Effects of Antipsychotics in Experimental Models of Krabbe Disease.

Journal: Biomedicines

Published: March 05, 2023

Elucidating the Therapeutic Utility of Olaparib in Sulfatide-Induced Human Astrocyte Toxicity and Neuroinflammation.

Elucidating the Therapeutic Utility of Olaparib in Sulfatide-Induced Human Astrocyte Toxicity and Neuroinflammation.

Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology

Published: January 09, 2023

Investigating the Effects of Olaparib on the Susceptibility of Glioblastoma Multiforme Tumour Cells to Natural Killer Cell-Mediated Responses.

Investigating the Effects of Olaparib on the Susceptibility of Glioblastoma Multiforme Tumour Cells to Natural Killer Cell-Mediated Responses.

Journal: Pharmaceutics

Published: December 16, 2022

Existing Evidence for the Repurposing of PARP-1 Inhibitors in Rare Demyelinating Diseases.

Existing Evidence for the Repurposing of PARP-1 Inhibitors in Rare Demyelinating Diseases.

Journal: Cancers

Published: December 01, 2021

Hybrid Nanoparticles as a Novel Tool for Regulating Psychosine-Induced Neuroinflammation and Demyelination In Vitro and Ex vivo.

Hybrid Nanoparticles as a Novel Tool for Regulating Psychosine-Induced Neuroinflammation and Demyelination In Vitro and Ex vivo.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: August 12, 2021

Fingolimod Rescues Memory and Improves Pathological Hallmarks in the 3xTg-AD Model of Alzheimer's Disease.

Fingolimod Rescues Memory and Improves Pathological Hallmarks in the 3xTg-AD Model of Alzheimer's Disease.

Journal: Molecular neurobiology

Published: May 24, 2021

EBI2 Is Temporarily Upregulated in MO3.13 Oligodendrocytes during Maturation and Regulates Remyelination in the Organotypic Cerebellar Slice Model.

EBI2 Is Temporarily Upregulated in MO3.13 Oligodendrocytes during Maturation and Regulates Remyelination in the Organotypic Cerebellar Slice Model.

Journal: International journal of molecular sciences

Published: March 01, 2021

Spatiotemporal immunolocalisation of REST in the brain of healthy ageing and Alzheimer's disease rats.

Spatiotemporal immunolocalisation of REST in the brain of healthy ageing and Alzheimer's disease rats.

Journal: FEBS open bio

Published: July 25, 2020

Showing 1-12 of 51

Last Updated: 09/26/2026